Neuland Laboratories Limited is engaged in manufacturing active pharmaceutical ingredient (API). The Company also provides Custom Manufacturing Solutions (CMS) to develop and manufacture pharmaceutical ingredients and intermediates. Its geographical segments include Europe, India, USA and Rest of the world. The Company's API products include Alcaftadine, Aripiprazole, Bosentan Monohydrate, Dabigatran Etexilate Mesylate, Deferasirox, Enalapril Maleate, Escitalopram Oxalate, Labetalol Hydrochloride, Posaconazole, Propofol, Ropinirole Hydrochloride, Ticagrelor, Levofloxacin Hemihydrate and Ciprofloxacin Base. It caters to therapeutic categories, including ophthalmic, schizophrenia, vasodilator, fluoroquinolones, ironchelator, chronic obstructive pulmonary disease and cardiovascular. The Company also offers peptide synthesis services, including manufacture of complex amino acids, and manufacture of peptide APIs, new chemical entities (NCEs) and impurities.